Yi-zhuo Li

Rapamycin and trametinib: a rational combination for treatment of NSCLC

Hui-Yun Wang, Mei-yin Zhang, Chao-Yue Sun, 2021, International journal of biological sciences.

BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer

Wenlin Huang, Ran-yi Liu, Xiang Fu, 2017, Cell Death & Disease.

ARHGEF19 interacts with BRAF to activate MAPK signaling during the tumorigenesis of non‐small cell lung cancer

Wenlin Huang, Ran-yi Liu, Shuai Chen, 2018, International journal of cancer.